T1	PROC 46 95	Estudio fase IIIB-IV de seguimiento a largo plazo
T2	PROC 175 211	Estudio de seguimiento a largo plazo
T3	DISO 231 250	esclerosis múltiple
#1	AnnotatorNotes T3	C0026769; Multiple Sclerosis; Disease or Syndrome
T4	PROC 273 293	estudio de extensión
T5	CHEM 297 308	alemtuzumab
#2	AnnotatorNotes T5	C0383429; alemtuzumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	DISO 345 388	Esclerosis múltiple en remisión de recaídas
T7	PROC 471 491	Estudio de Extensión
T8	PROC 633 656	estudio de intervención
#3	AnnotatorNotes T8	C3274035; Interventional Study; Research Activity
T9	PROC 531 555	consentimiento informado
#4	AnnotatorNotes T9	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T10	Date 13 17	2013
T12	Date 82 95	a largo plazo
T13	LIVB 101 110	pacientes
#5	AnnotatorNotes T13	C0030705; Patients; Patient or Disabled Group
T14	Date 198 211	a largo plazo
T15	LIVB 217 226	pacientes
#6	AnnotatorNotes T15	C0030705; Patients; Patient or Disabled Group
T16	LIVB 424 432	paciente
#7	AnnotatorNotes T16	C0030705; Patients; Patient or Disabled Group
T17	Duration 449 466	al menos 48 meses
T18	LIVB 598 606	paciente
#8	AnnotatorNotes T18	C0030705; Patients; Patient or Disabled Group
#9	AnnotatorNotes T2	C1517942; Long-term Follow-up; Health Care Activity 
#10	AnnotatorNotes T12	C0443252; Long-term; Temporal Concept 
#11	AnnotatorNotes T14	C0443252; Long-term; Temporal Concept 
#12	AnnotatorNotes T6	C0751967; Multiple Sclerosis, Relapsing-Remitting; Disease or Syndrome
#13	AnnotatorNotes T1	C1517942; Long-term Follow-up; Health Care Activity + C1706097; Trial Phase 3B; Research Activity + C0282462; Phase 4 Clinical Trials; Research Activity
R1	Overlap Arg1:T1 Arg2:T12	
T11	Observation 115 141	participaron en el estudio
A1	Status T11 History_of
#14	AnnotatorNotes T11	C1278516; Patient participation status; Finding (?)
R3	Before Arg1:T11 Arg2:T1	
R4	Overlap Arg1:T2 Arg2:T14	
R5	Experiences Arg1:T15 Arg2:T3	
T19	Observation 259 293	completado el estudio de extensión
#15	AnnotatorNotes T19	C2732579; Completion of clinical trial; Finding
R7	Overlap Arg1:T3 Arg2:T19	
R8	Experiences Arg1:T15 Arg2:T5	
R9	Has_Duration_or_Interval Arg1:T7 Arg2:T17	
T20	Observation 438 448;471 491	completado Estudio de Extensión
#16	AnnotatorNotes T20	C2732579; Completion of clinical trial; Finding
R10	Experiences Arg1:T16 Arg2:T20	
T21	Observation 612 656	participando en otro estudio de intervención
A2	Experiencer T13 Patient
A3	Experiencer T15 Patient
A4	Experiencer T16 Patient
A5	Experiencer T18 Patient
